Eloxx Pharmaceuticals, Inc. (ELOX)
12.75
-0.40
(-3.04%)
USD |
OTCM |
Nov 16, 16:00
Eloxx Pharmaceuticals Price to Book Value : 1.269 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.269 |
| November 13, 2026 | 1.308 |
| November 12, 2026 | 1.283 |
| November 11, 2026 | 1.295 |
| November 10, 2026 | 1.284 |
| November 09, 2026 | 1.344 |
| November 06, 2026 | 1.238 |
| November 05, 2026 | 1.274 |
| November 04, 2026 | 1.268 |
| November 03, 2026 | 1.286 |
| November 02, 2026 | 1.278 |
| October 30, 2026 | 1.338 |
| October 29, 2026 | 1.314 |
| October 28, 2026 | 1.306 |
| October 27, 2026 | 1.327 |
| October 26, 2026 | 1.310 |
| October 23, 2026 | 1.274 |
| October 22, 2026 | 1.306 |
| October 21, 2026 | 1.323 |
| October 20, 2026 | 1.316 |
| October 19, 2026 | 1.244 |
| October 16, 2026 | 1.297 |
| October 15, 2026 | 1.363 |
| October 14, 2026 | 1.215 |
| October 13, 2026 | 1.264 |
| Date | Value |
|---|---|
| October 12, 2026 | 1.382 |
| October 09, 2026 | 1.367 |
| October 08, 2026 | 1.510 |
| October 07, 2026 | 1.481 |
| October 06, 2026 | 1.506 |
| October 05, 2026 | 1.533 |
| October 02, 2026 | 1.543 |
| October 01, 2026 | 1.563 |
| September 30, 2026 | 1.523 |
| September 29, 2026 | 1.341 |
| September 28, 2026 | 1.304 |
| September 25, 2026 | 1.307 |
| September 24, 2026 | 1.391 |
| September 23, 2026 | 1.342 |
| September 22, 2026 | 1.455 |
| September 21, 2026 | 1.495 |
| September 18, 2026 | 1.517 |
| September 17, 2026 | 1.526 |
| September 16, 2026 | 1.533 |
| September 15, 2026 | 1.587 |
| September 14, 2026 | 1.417 |
| September 11, 2026 | 1.370 |
| September 10, 2026 | 1.416 |
| September 09, 2026 | 1.441 |
| September 08, 2026 | 1.406 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.4059 |
| CorMedix, Inc. | 0.8297 |
| Breakthrough Chemistry, Inc. | 1.592 |
| BioStem Technologies, Inc. | 0.9777 |
| Cardiac Biotech Solutions, Inc. | -- |
Price to Book Value Related Metrics
| Price | 12.75 |
| Earnings Yield | -20.29% |
| Market Cap | 51.46M |